Peringatan Keamanan

The toxicity has not been determined.

Sutilain

DB09379

biotech approved withdrawn

Deskripsi

Sutilain is a member of the keratase family which includes agents such as papain. It is able to dissolve the intercellular matrix which helps with desquamation. Sutilain contains proteolytic enzymes derived from Bacillus subtilis and it is available as a cream-colored odorless powder. One gram of sutilain powder contains 250,000 casein units of proteolytic activity.T169 Sutilain was developed by Abbott and FDA approved on June 12, 1969. It is currently discontinued.L2368

Struktur Molekul 2D

Struktur tidak tersedia

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) This pharmacokinetic parameter is not relevant.
Volume Distribusi This pharmacokinetic parameter is not relevant.
Klirens (Clearance) This pharmacokinetic parameter is not relevant.

Absorpsi

Sutilain is not absorbed.

Metabolisme

This pharmacokinetic parameter is not relevant.

Rute Eliminasi

This pharmacokinetic parameter is not relevant.

Interaksi Obat

0 Data
Tidak ada data.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 821152
    Coopwood TB: Evaluation of a topical enzymatic debridement agent--sutilains ointment: a preliminary report. South Med J. 1976 Jul;69(7):834-6.
Textbook
  • ISBN: 978-81-96396-15-2
    Kokate C., Purohit A. and Gokhale S. (2008). Pharmacognosy (42nd ed.). Pragati Book House.

Contoh Produk & Brand

Produk: 1 • International brands: 0
Produk
  • Travase Ointment 82000 Casein Units/gm
    Ointment • 82000 unit / g • Topical • Canada • Approved

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul